S&CO Inc’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $879K | Buy |
7,000
+2,000
| +40% | +$251K | 0.06% | 148 |
|
|
2025
Q1 | $553K | Hold |
5,000
| – | – | 0.04% | 169 |
|
|
2024
Q4 | $682K | Hold |
5,000
| – | – | 0.05% | 158 |
|
|
2024
Q3 | $576K | Hold |
5,000
| – | – | 0.04% | 171 |
|
|
2024
Q2 | $688K | Hold |
5,000
| – | – | 0.05% | 162 |
|
|
2024
Q1 | $689K | Buy |
+5,000
| New | +$689K | 0.05% | 158 |
|